These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8968213)

  • 1. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S2-13. PubMed ID: 8968213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis of inflammatory myopathies.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S74-86. PubMed ID: 8968219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: immune mechanism and update on current therapies.
    Bansil S; Cook SD; Rohowsky-Kochan C
    Ann Neurol; 1995 May; 37 Suppl 1():S87-101. PubMed ID: 8968220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Target antigens in neuroimmunological diseases].
    Tabira T
    Nihon Rinsho; 1994 Nov; 52(11):2855-60. PubMed ID: 7996680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes.
    Damle NK; Klussman K; Leytze G; Aruffo A; Linsley PS; Ledbetter JA
    J Immunol; 1993 Sep; 151(5):2368-79. PubMed ID: 7689606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
    Weathington NM; Blalock JE
    Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection.
    Dedrick RL; Bodary S; Garovoy MR
    Expert Opin Biol Ther; 2003 Feb; 3(1):85-95. PubMed ID: 12718733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there unique autoantigens triggering autoimmune diseases?
    Bach JF; Koutouzov S; van Endert PM
    Immunol Rev; 1998 Aug; 164():139-55. PubMed ID: 9795772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes.
    Damle NK; Aruffo A
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6403-7. PubMed ID: 1713678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
    Usui M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimmunology I: Immunoregulation in neurological disease.
    Weiner HL; Hauser SL
    Ann Neurol; 1982 May; 11(5):437-49. PubMed ID: 6179458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour therapy in paraneoplastic neurological disease.
    Grisold W; Drlicek M; Liszka-Setinek U; Wondrusch E
    Clin Neurol Neurosurg; 1995 Feb; 97(1):106-11. PubMed ID: 7788965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mosaic of immunosuppressive drugs.
    Masri MA
    Mol Immunol; 2003 Jul; 39(17-18):1073-7. PubMed ID: 12835079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic nervous system syndromes.
    Jaeckle KA
    Curr Opin Oncol; 1996 May; 8(3):204-8. PubMed ID: 8794147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.